Navigation Links
Mike Bridges Takes Home Four Gold Medals at IPF Masters World Powerlifting Championships; Says NutraCea's RiSolubles(R) is an Essential Part of his Training Regimen
Date:10/21/2008

PHOENIX, Oct. 21 /PRNewswire/ -- NutraCea (OTC Bulletin Board: NTRZ), a world leader in stabilized rice bran (SRB) nutrient research and technology, announced today that world champion powerlifter Mike Bridges received four gold medals for his performances in the squat, bench press and dead lift events and was named World Champion for the 198lb/90k division at the at IPF Masters World Powerlifting Championships in Palm Springs, CA. Bridges points to NutraCea's RiSolubles(R) as an essential component of his training. RiSolubles(R) is a highly nutritious rice-bran-derived nutritional supplement made by NutraCea. Bridges, 51, is not a paid spokesperson for the company.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081021/CLTU906 )

"Competing at this level is extreme and if a supplement is not effective, I'm not going to take it," commented Mike Bridges when asked about selecting supplements. "I've been taking RiSolubles(R) for over a year because it is an effective supplement that completes my dietary goals for supplying sustained energy, reduced recovery time and building lean muscle mass. Equally important to me is that RiSolubles(R) is all natural."

RiSolubles(R) delivers a concentrated nutritional profile and powerful antioxidant value in a light powder form. It is currently only available on NutraCea's website at http://www.nutracea.com.

"RiSolubles(R) is a fantastic product for professional athletes who are training for competition and we're elated to be a part of Mike Bridges' success in his most recent competitions," said Kody Newland, Senior Vice President of Sales at NutraCea. He continued, "We're seeing product sales within the sports nutrition arena grow, and it's because athletes are seeking the same benefits that Mike Bridges is experiencing."

About Mike Bridges

Since 2003, Br
'/>"/>

SOURCE NutraCea
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. LearnCDHC Bridges Education Gap on Consumer Directed Healthcare : Interactive Web resource engages and educates consumers about consumer-directed healthcare
2. Colorado Business Group on Health Expands Bridges to Excellence Physician Recognition and Rewards Program
3. Bridges to Excellence Marks Five-Year Anniversary
4. Bridges to Excellence Study Assesses Clinical and Financial Impact of Physician Quality Measures
5. Dental implants preferred option for aging bridges
6. Dental Implants Preferred Option for Aging Bridges
7. Empowering Your Patients: Smile Dash Portal Bridges Gap Between Dentists and Patients
8. Buyers Health Care Action Group Pilots New Bridges to Excellence Program for Depression
9. Blue Cross and Blue Shield of North Carolina Achieves Bridges to Excellence Certification
10. First Health Plans Receive Bridges to Excellence Endorsement and Certification
11. Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 2Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 3Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential 4ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4Winter Spare the Air Alert in Effect for Thursday November 26 2009 62162 1Winter Spare the Air Alert in Effect for Thursday November 26 2009 62162 2Heska Announces Supply Agreement With Roche Diagnostics 6549 1Heska Announces Supply Agreement With Roche Diagnostics 6549 2Heska Announces Supply Agreement With Roche Diagnostics 6549 3Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 1Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 2Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 3Engineers doctors at UCLA develop novel material that could help fight arterial disease 62158 4